Costanza Lagrasta Selected Research

Costanza Lagrasta Research Topics

Disease

10	Neoplasms (Cancer) 08/2020 - 04/2006
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 11/2007
3	Myocardial Infarction 01/2016 - 04/2010
2	Heart Failure 01/2022 - 05/2003
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 05/2003
2	Fibrosis (Cirrhosis) 01/2021 - 03/2011
2	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 08/2007
2	Ventricular Dysfunction 01/2012 - 03/2006
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2011 - 04/2008
2	Hypertrophy 03/2011 - 08/2007
2	Infarction (Infarctions) 03/2011 - 03/2006
1	Heart Diseases (Heart Disease) 01/2022
1	Disease Progression 01/2021
1	Colonic Neoplasms (Colon Cancer) 12/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2015
1	Circulating Neoplastic Cells 01/2015
1	Hyperglycemia 01/2012
1	Ventricular Remodeling 01/2012
1	Neoplasm Metastasis (Metastasis) 05/2011
1	Lung Neoplasms (Lung Cancer) 04/2010
1	Small Cell Carcinoma 04/2008
1	Large Cell Carcinoma 04/2008
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2007
1	Adenoma (Adenomas) 08/2007
1	Body Weight (Weight, Body) 08/2007
1	Breast Neoplasms (Breast Cancer) 04/2006
1	Hypertension (High Blood Pressure) 08/2005
1	Atherosclerosis 08/2005
1	Cardiomegaly (Heart Hypertrophy) 05/2003

Drug/Important Bio-Agent (IBA)

5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 11/2007
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2008
3	ParaffinIBA 03/2010 - 01/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 05/2011
2	Bevacizumab (Avastin)FDA Link 12/2019 - 01/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2019 - 03/2011
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016 - 03/2011
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2016 - 03/2006
2	Proteins (Proteins, Gene)FDA Link 05/2011 - 11/2007
2	DNA (Deoxyribonucleic Acid)IBA 03/2010 - 04/2008
2	Gefitinib (Iressa)FDA Link 03/2010 - 11/2007
2	AnthracyclinesIBA 01/2010 - 04/2006
1	human KAT2A proteinIBA 01/2022
1	LipidsIBA 01/2022
1	EnzymesIBA 01/2022
1	AfatinibIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	osimertinibIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	LigandsIBA 01/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2019
1	Epidermal Growth Factor (EGF)IBA 12/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2019
1	AngiopoietinsIBA 12/2019
1	RNA (Ribonucleic Acid)IBA 12/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2016
1	CrizotinibIBA 11/2015
1	AntigensIBA 01/2015
1	Epithelial Cell Adhesion MoleculeIBA 01/2015
1	ResveratrolIBA 01/2012
1	CalciumIBA 01/2012
1	Trastuzumab (Herceptin)FDA Link 05/2011
1	Humanized Monoclonal AntibodiesIBA 05/2011
1	Connexin 43 (Connexin43)IBA 03/2011
1	Insulin (Novolin)FDA Link 03/2011
1	Bromodeoxyuridine (BrdU)IBA 03/2011
1	Messenger RNA (mRNA)IBA 03/2011
1	Cadherins (E-Cadherin)IBA 03/2011
1	CytokinesIBA 03/2011
1	Nerve Growth Factor (NGF)IBA 04/2010
1	trkA ReceptorIBA 04/2010
1	TropomyosinIBA 04/2010
1	Biological ProductsIBA 01/2010
1	Formaldehyde (Formol)FDA Link 04/2008
1	Mitogen-Activated Protein KinasesIBA 11/2007
1	CollagenIBA 08/2007
1	Calcibiotic Root Canal SealerIBA 08/2007
1	Superoxide DismutaseIBA 08/2007
1	Adrenergic Agents (Adrenergic Drugs)IBA 08/2007
1	Biomarkers (Surrogate Marker)IBA 04/2006
1	Tissue Kallikreins (Tissue Kallikrein)IBA 03/2006
1	GTP-Binding Proteins (G-Protein)IBA 08/2005
1	Angiotensin IIIBA 08/2005
1	KininsIBA 05/2003

Therapy/Procedure

4	Therapeutics 12/2019 - 01/2010
2	Immunotherapy 08/2020 - 01/2020
2	Drug Therapy (Chemotherapy) 12/2019 - 04/2006
1	Microspheres (Microsphere) 01/2021
1	Neoadjuvant Therapy 04/2006